← Full daily brief

Mass Tort brief

London's Courts Take Command of Mega-Litigation

From a £36bn dam disaster to AI liability overhauls, English judges are reshaping multi-billion-pound mass tort exposure.

Signalpoint TeamBrief

Mass Tort

GSK's $2.2bn settlement draws a line under the multi-year Zantac litigation — paying to eliminate a costly mass tort cloud that weighed on its FTSE share price.

BackgroundZantac was pulled from global pharmacy shelves in 2019 after laboratories detected high levels of NDMA, a probable human carcinogen, in ranitidine formulations. The multi-year US mass tort litigation previously erased billions in market capitalization from London-listed GSK.

Points
  1. GSK struck deals with ten claimant law firms representing 80,000 plaintiffs, resolving the vast majority of pending state court cases and halting imminent trials.
  2. The drugmaker took a £1.8bn pre-tax accounting charge while maintaining that scientific consensus demonstrates Zantac does not increase cancer risks.
  3. Resolving the litigation overhang protects GSK's UK dividend cash flows and allows management to refocus capital on its core vaccine and oncology pipelines.

Mass Tort

The High Court ruling keeps the £36bn Mariana dam group action intact — securing Pogust Goodhead's lead role and keeping multi-billion-pound liability pressure on BHP.

BackgroundThe 2015 collapse of the Fundão tailings dam in Brazil killed 19 people and devastated hundreds of miles of the Doce river basin. The ongoing English High Court action against mining titan BHP represents the largest group mass tort litigation in UK legal history.

Points
  1. Mr Justice Waksman held that a 17-member claimant committee lacked legal authority to terminate retainers or transfer 400,000 claimants to a rival firm, preventing severe procedural delays.
  2. The ruling shields hundreds of thousands of Brazilian claimants from immediate exposure to £2bn in potential adverse legal costs under English litigation rules.
  3. The judgment solidifies legal representation for claimants ahead of the Phase 2 trial, which will determine multi-billion-pound financial liabilities for BHP.

Mass Tort

The Law Commission's proposals bring British product liability law into the digital age — exposing AI developers and software platforms to strict consumer injury liability.

BackgroundThe Consumer Protection Act 1987 was drafted for physical manufacturing defects, creating legal ambiguity over whether standalone digital code or AI models constitute a product. The European Union recently passed its revised Product Liability Directive, prompting Westminster to modernise UK liability law.

Points
  1. The consultation paper proposes classifying standalone software, AI platforms, and algorithmic recommendation feeds as physical products under strict liability rules, removing common-law negligence hurdles.
  2. Online marketplaces and fulfilment providers would face statutory liability for defective goods sold via third-party digital platforms, closing a loophole that left consumers uncompensated.
  3. The review proposes reducing procedural evidence hurdles for consumers suffering harm from complex automated software and connected medical hardware, shifting the evidentiary burden onto developers.

Mass Tort

The EU's revised product rules make suing tech and hardware firms far easier — forcing British manufacturers to navigate twin liability regimes across the Irish Sea.

BackgroundThe revised EU Product Liability Directive introduces legal presumptions of defect in technically complex cases and mandates early disclosure of trade secrets during litigation. Under post-Brexit agreements, Northern Ireland remains aligned with EU product liability rules.

Points
  1. The directive permits courts to presume product defect whenever claimants face technical barriers to proving software causation, fundamentally reversing traditional burdens of proof.
  2. Manufacturers must disclose internal technical documentation and algorithmic training data early during mass personal injury proceedings, exposing commercially sensitive intellectual property.
  3. British cross-border manufacturers face compliance overheads managing divergent liability regimes across Great Britain and Northern Ireland, requiring separate warranty and testing frameworks.

Mass Tort

Mass Tort

Unlock the full brief

Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.

Or read free in the appDownload on the App Store